REGENXBIO Names Mitchell Chan As Executive Vice President And CFO, Effective Today
Portfolio Pulse from Benzinga Newsdesk
REGENXBIO has appointed Mitchell Chan as the new Executive Vice President and CFO, replacing Vit Vasista, who will remain as an advisor until January 2025 to ensure a smooth transition.
September 17, 2024 | 11:12 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
REGENXBIO has appointed Mitchell Chan as the new Executive Vice President and CFO, replacing Vit Vasista. Vasista will remain as an advisor until January 2025 to ensure a smooth transition.
The appointment of a new CFO can impact investor confidence and company strategy. However, the presence of the outgoing CFO as an advisor until 2025 suggests a stable transition, likely resulting in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 80